Updates on Kidney Transplantation From the World Transplant Congress 2025

Area of Science:

• Transplantation immunology
• Regenerative medicine
• Medical technology

Background:

• Global organ transplantation faces challenges including donor shortages and graft rejection.
• Existing immunosuppressive therapies have limitations in long-term efficacy and side effect profiles.
• The need for personalized approaches in transplantation is increasingly recognized.

Purpose of the Study:

• To summarize key advancements presented at the World Transplant Congress 2025.
• To highlight innovations addressing organ availability, patient sensitization, and graft longevity.
• To discuss the integration of novel technologies and therapeutic strategies in transplantation.

Main Methods:

• Review of data and findings from the World Transplant Congress 2025.
• Analysis of emerging clinical standards, including machine perfusion and novel immunosuppressive agents.
• Exploration of new diagnostic and prognostic tools, such as artificial intelligence in multiomics data analysis.

Main Results:

• Machine perfusion is becoming a clinical standard, rescuing discarded kidneys and enabling ex vivo repair.
• Novel desensitization regimens with proteasome inhibitors and anti-CD38 antibodies reduce donor-specific antibodies in highly sensitized patients.
• Emerging immunosuppressive strategies, including anti-CD38 antibodies and costimulatory blockade, show promise for improving graft survival and enabling drug minimization.

Conclusions:

• Innovations in machine perfusion, desensitization, immunosuppression, and AI are transforming transplantation.
• These advancements offer solutions for organ shortage, rejection, and the move towards precision medicine in transplant care.
• The future of transplantation involves individualized treatments and improved long-term graft outcomes.